In 2023, Stephen R. Davis earned $5.64M in total compensation at Acadia Pharmaceuticals, including $862.12K salary, $886.18K bonus and $3.87M in stock. Most recently sold 31,747 shares in Aug 2024. Currently holds stock worth $5.19M. Led Acadia Pharmaceuticals as CEO for 9 years.
Compensation History
Annual executive compensation data for Stephen R. Davis, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$5.64M
Salary
$862.12K
Bonus
$886.18K
Other
$30.57K
Salary
$862.12KBoard Justification
The compensation philosophy is designed to align executive compensation with business objectives and corporate performance, attract and retain talent, and link compensation with stockholder interests through long-term incentives.
Bonus
$886.18KBoard Justification
The bonus is based on the achievement of corporate performance goals, with a target bonus of 80% of base salary, resulting in a payout of approximately 129% of target for 2023.
Other Compensation
$30.57KBoard Justification
Other compensation includes employer contributions to the 401(k) plan and other benefits.
Restricted Stock
Board Justification
The vested stock consists of restricted stock units (RSUs) that were granted and vested in 2023.
Performance Metrics
The performance metrics for 2023 included net product sales of NUPLAZID and DAYBUE, NDA approvals, and other strategic goals.
Stephen R. Davis
Ex-CEO of Acadia Pharmaceuticals
Education
Not specified
Sector of Economy
Healthcare
Born
January 1, 1961 - 64 years ago
CEO of Acadia Pharmaceuticals for
9 years 0 months (Sep 2015 - Sep 2024)
Previous Experience
Executive Vice President and Chief Operating Officer at Heron Therapeutics, Inc.
Other Acadia Pharmaceuticals CEOs
Holdings
Track Stephen R. Davis's stock holdings and portfolio value over time.
Total Stock Sold
$33.32M
$33.32M
898,413 ACAD shares
What if they kept their stock?
If Stephen R. Davis didn't sell their stock, today they would have:
Extra ACAD898,413 shares worth $24.65M.
This is -26.02% and $8.67M less than what they got when they sold the stock.
Insider Trading
Stephen R. Davis's recent stock transactions, purchases, and sales filed with the SEC.
$485.09K
ACAD at $15.28/share
Aug 16, 2024
Sale
62,115 shares
ACAD
Aug 16, 2024
Received
$193.57K
ACAD at $16.94/share
May 1, 2024
Sale
$474.88K
ACAD at $17.87/share
Apr 5, 2024
Sale
$317.08K
ACAD at $17.90/share
Mar 25, 2024
Sale
34,666 shares
ACAD
Mar 25, 2024
Received
$137.58K
ACAD at $24.67/share
Feb 23, 2024
Sale
$111.81K
ACAD at $29.96/share
Jan 6, 2024
Sale
$1.13M
ACAD at $21.96/share
Oct 5, 2023
Sale
$3.00M
ACAD at $30.04/share
Jul 14, 2023
Sale
Rivals
Compare Stephen R. Davis with competitor CEOs and industry peers.